Reply: Inflammatory Pathways in CVD and Diabetes: Broad-Spectrum Versus Selective Targeting

J Am Coll Cardiol. 2018 Sep 18;72(12):1432-1433. doi: 10.1016/j.jacc.2018.07.021.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Anti-Inflammatory Agents
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Cardiovascular Diseases*
  • Diabetes Mellitus*
  • Humans

Substances

  • Anti-Inflammatory Agents
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • canakinumab